BMC Cancer

Published by: Biomed Central Ltd  

People

  1. O'Reilly
    O'Reilly
  2. Healey
    Healey
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Capanu
    Capanu
  6. Chou
    Chou
  7. Jungbluth
    Jungbluth
  8. La Quaglia
    La Quaglia
  9. Ladanyi
    Ladanyi
  10. Socci
    Socci

Groups

  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (21)
  3. Surgery (13)
  4. Survivorship Research (12)
  5. GSK Faculty (10)
  6. Epidemiology and Biostatistics (9)
  7. Center for Pancreatic Cancer Research (8)
  8. Population Sciences Research Program (8)
  9. Gastrointestinal Oncology Service (7)
  10. Genitourinary Oncology Service (7)
Search Within
Formats
  1. Journal Article (61)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (21)
  3. Surgery (13)
  4. Survivorship Research (12)
  5. GSK Faculty (10)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Sara Olson (5)
  2. Eileen O'Reilly (4)
  3. John Healey (3)
  4. Robert Motzer (3)
  5. Achim Jungbluth (2)
  6. Ghassan Abou-Alfa (2)

More People

Years
  1. 2022 (6)
  2. 2021 (4)
  3. 2020 (4)
  4. 2019 (2)
  5. 2018 (8)
  6. 2017 (5)

More Years

Publishers
  1. Biomed Central Ltd (61)

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
    Journal Article

    Schöffski, P.; George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Serrano, C.; Jones, R. L.; Attia, S.; D’Amato, G.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Rationale and design of ON-TRK: A novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
    Journal Article

    Yang, J. C. H.; Brose, M. S.; Castro, G.; Kim, E. S.; Lassen, U. N.; Leyvraz, S.; Pappo, A.; López‐Ríos, F.; Reeves, J. A.; Fellous, M.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
    Journal Article

    El-Khoueiry, A. B.; Meyer, T.; Cheng, A. L.; Rimassa, L.; Sen, S.; Milwee, S.; Kelley, R. K.; Abou-Alfa, G. K.
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
    Journal Article

    ten Hoorn, S.; Waasdorp, C.; van Oijen, M. G. H.; Damhofer, H.; Trinh, A.; Zhao, L.; Smits, L. J. H.; Bootsma, S.; van Pelt, G. W.; Mesker, W. E.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Relationship between insurance status and interhospital transfers among cancer patients in the United States
    Journal Article

    Rubens, M.; Ramamoorthy, V.; Saxena, A.; Appunni, S.; Sundil, S.; Veledar, E.; McGranaghan, P.; Tonse, R.; Fitz, S. J. T.; Chuong, M. D.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: An open-label, multi-center phase I study
    Journal Article

    Schaff, L. R.; Lobbous, M.; Carlow, D.; Schofield, R.; Gavrilovic, I. T.; Miller, A. M.; Stone, J. B.; Piotrowski, A. F.; Sener, U.; Skakodub, A.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Acute limb ischemia in a cancer patient has high morbidity, high mortality, and atypical presentation: A tertiary cancer center’s retrospective study
    Journal Article

    Bryce, Y.; Emmanuel, A. Jr; Agrusa, C.; Ziv, E.; Harnain, C.; Huq, S.; Santos Martin, E.
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
    Journal Article

    Powles, T.; Choueiri, T. K.; Motzer, R. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Kaldate, R.; Scheffold, C.; Wang, E.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
    Journal Article

    Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
    Journal Article

    Askan, G.; Sahin, I. H.; Chou, J. F.; Yavas, A.; Capanu, M.; Iacobuzio-Donahue, C. A.; Basturk, O.; O’Reilly, E. M.
    BMC Cancer (2021)

    Fulltext@MSK | Save

    • BMC Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 Estilo et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 Benchikh et al Licensee Biomed Central Ltd
    BMC Cancer 1471-2407 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd
    Bmc Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 The Author(s)
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    Bmc Cancer 1471-2407 Bmc
    BMC Cancer 14712407 de Moor et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 Lavarino et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 2022, The Author(s)
    BMC Cancer 14712407 Quintana et al Licensee Biomed Central Ltd
    BMC Cancer 1470-2045 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd